Immunotherapy in genitourinary cancers: Where are we going?

ANTONIO LOPEZ BELTRAN2026-01-292026-01-29201710.1080/23808993.2017.13214662-s2.0-85054840441https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/29676Drug DiscoveryGeneticsMolecular MedicinePharmacologyImmunotherapy in genitourinary cancers: Where are we going?research article